Efficacy and safety of Ginkgo biloba leaf extract injection for vascular cognitive impairment: a systematic review and meta-analysis
Frontiers in Pharmacology · 13.04.2026 · 17
DOI: 10.3389/fphar.2026.1720444 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Frontiers in Pharmacology, online erschienen am 13.04.2026. Verfasst von Jingchao Miao und 8 weiteren Autor:innen. Beteiligte Einrichtung: Evidence-Based Medicine Center, Tianjin University of Traditional Chinese Medicine, Tianjin, China. Die Arbeit nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Shuxuening injection (SXNI), a standardized injectable formulation of Ginkgo biloba leaf extract, is widely used in China for vascular cognitive impairment (VCI), However, evidence-based evaluation remains limited.
Methods
Randomized controlled trials published before 1 September 2025, were searched in eight databases. Patients had vascular cognitive impairment (VCI), with the control group receiving conventional treatment and the treatment group receiving additional SXNI therapy. The primary outcome was the Mini-Mental State Examination (MMSE), while secondary outcomes included the Hasegawa Dementia Scale (HDS), Barthel Index (BI), overall response rate, National Institutes of Health Stroke Scale (NIHSS), and adverse event incidence. Risk of bias was assessed using the revised Cochrane Risk of Bias tool. Risk ratios (RR) were used for binary variables; mean differences (MD) with 95% confidence intervals (CI) were used for continuous variables.
Results
Twenty-two trials (n = 2,375) were included. All trials were conducted in China between 2005 and 2025. Compared with the control group, SXNI was associated with higher MMSE (MD 3.61, 95% CI 3.06–4.17), HDS (MD 1.30, 95% CI 0.21–2.39), and BI (MD 9.06, 95% CI 4.66–13.45), a higher overall response rate (RR 1.27, 95% CI 1.21–1.33), and lower NIHSS (MD −6.17, 95% CI −7.90 to −4.45). Seven studies reported adverse events; and there was no significant difference in the incidence of adverse events (RR 0.72, 95% CI 0.36–1.44).
Conclusion
The addition of SXNI to conventional treatment may provide additional benefits in cognition, neurological function, and activities of daily living with no significant increase in reported adverse events compared with conventional treatment. However, the certainty of evidence is limited by methodological weaknesses and uncertainty regarding the comparability of preparations from different manufacturers. Therefore, high-quality studies are needed to confirm these findings. Systematic Review Registration https://www.crd.york.ac.uk/PROSPERO/display_record.php?RecordID=557472 , identifier CRD42024557472.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Evidence-Based Medicine Center, Tianjin University of Traditional Chinese Medicine, Tianjin, China.
- Haihe Laboratory of Modern Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin, China.
- First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, National Clinical Research Center for Chinese Medicine, Tianjin, China.
- Traditional Chinese Medical College, North China University of Science and Technology, Tangshan, Hebei, China.
Zitieren
APA
Miao, J., Liu, Y., Feng, H., Zan, S., Miao, C., Wang, J., Jin, X., Yang, F., & Pang, W. (2026). Efficacy and safety of Ginkgo biloba leaf extract injection for vascular cognitive impairment: a systematic review and meta-analysis. Frontiers in Pharmacology, 17. https://doi.org/10.3389/fphar.2026.1720444
Vancouver
Miao J, Liu Y, Feng H, Zan S, Miao C, Wang J, et al. Efficacy and safety of Ginkgo biloba leaf extract injection for vascular cognitive impairment: a systematic review and meta-analysis. Frontiers in Pharmacology. 2026;17. doi:10.3389/fphar.2026.1720444
BibTeX
@article{Miao2026,
author = {Miao, Jingchao and Liu, Yaoyuan and Feng, Huichuan and Zan, Shujie and Miao, Changhong and Wang, Jiabao and Jin, Xinyao and Yang, Fengwen and Pang, Wentai},
title = {Efficacy and safety of Ginkgo biloba leaf extract injection for vascular cognitive impairment: a systematic review and meta-analysis},
journal = {Frontiers in Pharmacology},
year = {2026},
volume = {17},
doi = {10.3389/fphar.2026.1720444}
}
EUVIMED